论文信息 - MA21.10 Phase II Study of 160mg of Osimertinib in EGFR T790M Positive NSCLC with Brain or Leptomeningeal Metastases Who Progressed on Prior EGFR TKI - 字舞流文

MA21.10 Phase II Study of 160mg of Osimertinib in EGFR T790M Positive NSCLC with Brain or Leptomeningeal Metastases Who Progressed on Prior EGFR TKI

Jong-Mu Sun | K. Park | J. O. Park | H. Jung | Joonghyun Ahn | S. Park | M. Ahn | S. Hong | S. Lee | M. Park